FDA Peptide Update: Category 2 Removals Explained FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion FDA Proposes Exclusion of Semaglutide, Tirzepatide, Liraglutide from 503B Bulks List FDA posted on the topic LinkedIn Q&A: Should you trust trending peptide injections? FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News